Rating Change
JP Morgan reiterated its Overweight rating on Edgewise Therapeutics, Inc. Common Stock (NASDAQ:EWTX) on August 20, 2026.
reiterateNASDAQ:EWTX
JP Morgan Reiterates Overweight Rating on Edgewise Therapeutics, Inc. Common Stock (EWTX)
JP Morgan reiterated its Overweight rating on Edgewise Therapeutics, Inc. Common Stock (NASDAQ:EWTX) on August 20, 2026.
At publication ·
What changed
Edgewise Therapeutics, Inc. Common Stock (NASDAQ:EWTX) · reiterate
- Firm
- JP Morgan
- Rating
- Overweight to Overweight
- Price at event
- $43.29
- Market capitalization
- $2.5B
At a glance
Key takeaways
- JP Morgan reiterated an Overweight rating on Edgewise Therapeutics (EWTX) on August 20, 2026, with the stock trading at $43.29 and a market capitalization of $2.5 billion.
- Among the 10 most recent analyst ratings, 8 are Buy, 2 are Hold, and 0 are Sell, indicating predominantly positive sentiment from the analyst community.
Market Context
Edgewise Therapeutics, Inc. Common Stock operates in the Healthcare sector. The stock currently trades at $43.29 with a market capitalization of $2.5B.
Analyst coverage from JP Morgan provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Edgewise Therapeutics, Inc. Common Stock.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Edgewise Therapeutics, Inc. Common Stock
Among the 10 most recent ratings: 8 Buy, 2 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 20, 2026 | JP Morgan | Overweight | N/A |
| Aug 11, 2026 | Goldman Sachs | Neutral | N/A |
| Jul 20, 2026 | Evercore ISI Group | Outperform | N/A |
| Jul 09, 2026 | Oppenheimer | Outperform | N/A |
| Jul 06, 2026 | Guggenheim | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View EWTX Stock Page
Frequently Asked Questions
What does the Overweight rating mean for EWTX?
A rating of Overweight from JP Morgan reflects the analyst's outlook on Edgewise Therapeutics, Inc. Common Stock (NASDAQ:EWTX). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the EWTX forecast page.
